Retrospective / Prospective Clinical Study of AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric Intraocular Lenses

Retrospective / Prospective Clinical Study of AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric Intraocular Lenses

The purpose of this study is to characterize the safety and effectiveness of the ACRYSOF IQ ReSTOR +2.5 diopter (D) Multifocal Toric Intraocular Lens (IOL) in subjects at least 3 months and no more than 14 months after IOL implantation.

This is a retrospective and prospective clinical study comprised of a retrospective chart review for preoperative, surgical and early postoperative data, and a prospective postoperative visit conducted at least 3 months but not more than 14 months after IOL implantation.

Inclusion Criteria:

• Must sign an informed consent form and be willing to come in for a visit at least 3 months and not more than 14 months after IOL implantation with the AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric IOL (Models SV25T2, SV25T3, SV25T4 and SV25T5);
• Must be implanted with the correct lens based on preoperative corneal astigmatism as specified in the protocol;
• Must complete a visit within 10 days after IOL implantation;
• Successful capsular bag implantation with no surgical complications;
• Other protocol-specified inclusion criteria may apply.

Exclusion Criteria:

• IOL implanted prior to the AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric IOL;
• Ocular or intraocular infection or inflammation at the time of the preoperative visit;
• Any ocular surgery or intraocular laser procedure at or prior to the surgical visit;
• Any conditions affecting the cornea (eg. corneal dystrophy, severe dry eye) at the preoperative visit;
• Retinal conditions (e.g. degenerative retinal conditions, history of retinal detachment, diabetic retinopathy) at the preoperative visit;
• Known history of Type 1 or 2 diabetes for more than 5 years;
• Any ocular or systemic co-morbidity at the preoperative visit;
• Pregnant at the preoperative visit or at the time of Postoperative Visit 2;
• Preoperative corneal astigmatism ≤ 0.50 D;
• Participation in another clinical study at the preoperative visit or at the time of the final study visit;
• Other protocol-specified exclusion criteria may apply.